East Greenwich, RI, United States of America

Karen J Ferrante

This inventor holds 2 USPTO granted patents. Top assignee: Osi Pharmaceuticals, Inc.. Active years: 2005-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karen J Ferrante. Retrieved from https://idiyas.com/inventor/karen-j-ferrante

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Karen J. Ferrante

Introduction

Karen J. Ferrante is a prominent inventor based in East Greenwich, Rhode Island. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of abnormal cell growth. With a total of 2 patents, her work focuses on innovative methods to combat diseases such as cancer.

Latest Patents

Ferrante's latest patents include groundbreaking methods for treating abnormal cell growth. One patent describes a method of monotherapy for subjects suffering from abnormal cell growth expressing the epidermal growth factor receptor (EGFR). This method involves orally administering a therapeutically effective amount of a crystalline polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride. The second patent relates to a stable crystalline form of the same compound, designated as the B polymorph. This invention details its production in pure form and its pharmaceutical applications in treating hyperproliferative disorders.

Career Highlights

Karen J. Ferrante is currently associated with Osi Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating effective treatments that address critical health issues.

Collaborations

Throughout her career, Ferrante has collaborated with notable colleagues, including Timothy Norris and Jeffrey W. Raggon. These partnerships have enhanced her research and contributed to the success of her innovative projects.

Conclusion

Karen J. Ferrante's contributions to the field of pharmaceuticals exemplify her dedication to innovation and improving patient outcomes. Her patents reflect her commitment to advancing medical science and providing effective treatments for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…